08049 吉林长龙药业
按盘价 
1.850 +0.030 (+1.648%) | 2023/12 - 末期 人民币() | 2022/12 人民币() | 2021/12 人民币() | 2020/12 人民币() | 2019/12 人民币() | |
| 经营活动之现金流量 | 315,947,000 | 203,992,000 | 215,090,000 | 151,227,000 | 132,509,000 |
| 投资活动之现金流量 | 109,043,000 | (117,971,000) | (160,614,000) | (244,848,000) | (129,067,000) |
| 融资活动之现金流量 | (186,454,000) | (27,714,000) | (25,199,000) | (17,751,000) | (24,393,000) |
| 现金及等同现金之增加/(减少) | 238,536,000 | 58,307,000 | 29,277,000 | (111,372,000) | (20,951,000) |
| 期初之现金及现金等价物 | 113,601,000 | 55,294,000 | 26,017,000 | 137,389,000 | 158,340,000 |
| 汇率变动之影响 | 0 | 0 | 0 | 0 | 0 |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 期末之现金及现金等价物 | 352,137,000 | 113,601,000 | 55,294,000 | 26,017,000 | 137,389,000 |
| 备注： | 实时报价更新时间为25/04/2024 18:00 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB 148,207,000 |
| 增长率 | -23.433% |
| 每股盈利/(亏损) | RMB 0.265 |
| 每股账面资产净值 (¥) | RMB 2.642 |